Your browser doesn't support javascript.
loading
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.
Chen, Wen-Hsiang; Wei, Junfei; Kundu, Rakhi Tyagi; Adhikari, Rakesh; Liu, Zhuyun; Lee, Jungsoon; Versteeg, Leroy; Poveda, Cristina; Keegan, Brian; Villar, Maria Jose; de Araujo Leao, Ana C; Rivera, Joanne Altieri; Gillespie, Portia M; Pollet, Jeroen; Strych, Ulrich; Zhan, Bin; Hotez, Peter J; Bottazzi, Maria Elena.
Afiliação
  • Chen WH; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Wei J; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Kundu RT; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Adhikari R; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Liu Z; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Lee J; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Versteeg L; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Poveda C; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Keegan B; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Villar MJ; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • de Araujo Leao AC; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Rivera JA; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Gillespie PM; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Pollet J; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Strych U; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Zhan B; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Hotez PJ; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A. Baker
  • Bottazzi ME; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A. Baker
Biochim Biophys Acta Gen Subj ; 1865(6): 129893, 2021 06.
Article em En | MEDLINE | ID: mdl-33731300

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Saccharomycetales / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 Idioma: En Revista: Biochim Biophys Acta Gen Subj Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Saccharomycetales / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 Idioma: En Revista: Biochim Biophys Acta Gen Subj Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos